Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Avidity Biosciences Inc (RNA)

Avidity Biosciences Inc (RNA)
31.80 +0.08 (+0.25%) 13:49 ET [NASDAQ]
31.72 x 68 31.83 x 5
Realtime by (Cboe BZX)
31.72 x 68 31.83 x 5
Realtime 31.06 -0.66 (-2.08%) 09:30 ET
Quote Overview for Thu, Mar 20th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
30.78
Day High
32.22
Open 31.06
Previous Close 31.72 31.72
Volume 494,308 494,308
Avg Vol 1,315,581 1,315,581
Stochastic %K 42.55% 42.55%
Weighted Alpha -4.31 -4.31
5-Day Change -0.25 (-0.78%) -0.25 (-0.78%)
52-Week Range 21.56 - 56.00 21.56 - 56.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,813,125
  • Shares Outstanding, K 120,212
  • Annual Sales, $ 10,900 K
  • Annual Income, $ -322,300 K
  • EBIT $ -379 M
  • EBITDA $ -398 M
  • 60-Month Beta 1.02
  • Price/Sales 336.24
  • Price/Cash Flow N/A
  • Price/Book 2.55

Options Overview Details

View History
  • Implied Volatility 101.30% ( +2.36%)
  • Historical Volatility 64.43%
  • IV Percentile 94%
  • IV Rank 68.93%
  • IV High 119.75% on 03/13/25
  • IV Low 60.36% on 08/19/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 159
  • Volume Avg (30-Day) 353
  • Put/Call OI Ratio 1.95
  • Today's Open Interest 15,202
  • Open Int (30-Day) 11,723

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.88
  • Number of Estimates 4
  • High Estimate -0.61
  • Low Estimate -1.05
  • Prior Year -0.79
  • Growth Rate Est. (year over year) -11.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.64 +15.33%
on 03/04/25
Period Open: 32.53
36.38 -12.37%
on 03/13/25
-0.65 (-2.00%)
since 02/20/25
3-Month
26.74 +19.22%
on 01/14/25
Period Open: 31.82
36.38 -12.37%
on 03/13/25
+0.06 (+0.19%)
since 12/20/24
52-Week
21.56 +47.87%
on 04/04/24
Period Open: 24.24
56.00 -43.07%
on 11/13/24
+7.64 (+31.52%)
since 03/20/24

Most Recent Stories

More News
Insider Sale: CSTO of $RNA (RNA) Sells 24,000 Shares

W. Michael Flanagan, the CSTO of $RNA ($RNA), sold 24,000 shares of the company on 12-11-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 21.9% of their shares....

RNA : 31.80 (+0.25%)
Insider Sale: Chief Human Resources Officer of $RNA (RNA) Sells 25,000 Shares

Teresa McCarthy, the Chief Human Resources Officer of $RNA ($RNA), sold 25,000 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

RNA : 31.80 (+0.25%)
Avidity Biosciences (RNA) Stock Surges on Positive AOC 1020 Trial Results

Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase comes following impressive results from Avidity’s AOC 1020 clinical trial...

RNA : 31.80 (+0.25%)
2 Promising Growth Stocks to Buy and Hold for a Decade or Longer

These two growth stocks could be great additions to a long-term buy-and-hold portfolio.

RNA : 31.80 (+0.25%)
$SPX : 5,658.36 (-0.30%)
LLY : 846.21 (+1.10%)
UBER : 74.31 (+1.77%)
CART : 38.96 (-1.96%)
BMY : 59.96 (-0.20%)
Why Avidity Biosciences Zoomed to a 12% Gain This Week

The company's most promising pipeline program can continue unabated.

RNA : 31.80 (+0.25%)
GS : 563.27 (+1.06%)
Stocks Pressured by Middle East Risks

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.15%. Stocks today are...

NVDA : 118.45 (+0.79%)
CEG : 219.29 (+0.57%)
RNA : 31.80 (+0.25%)
$SPX : 5,658.36 (-0.30%)
ADI : 205.49 (-2.13%)
HIMS : 32.89 (-2.92%)
NXPI : 203.62 (-1.81%)
TSCO : 52.10 (-1.33%)
LUV : 33.79 (+0.57%)
ACN : 299.72 (-7.63%)
$IUXX : 19,647.79 (-0.45%)
STM : 24.43 (-4.12%)
2 Standout Biotech Stocks With 32% to 63% Upside

A strong pipeline of products could potentially transform these companies, but there are risks.

RNA : 31.80 (+0.25%)
$SPX : 5,658.36 (-0.30%)
BMY : 59.96 (-0.20%)
VRNA : 65.80 (-0.44%)
3 Russell 2000 Growth Stocks That Could Be Worth the Risk

These three small-cap stocks could deliver hefty returns if the central bank cuts rates.

LBPH : 59.98 (+0.03%)
RNA : 31.80 (+0.25%)
SOUN : 9.78 (-0.71%)
Avidity Biosciences (RNA) Stock Surges on Positive AOC 1020 Trial Results

Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase comes following impressive results from Avidity’s AOC 1020 clinical trial...

RNA : 31.80 (+0.25%)
Chart of the Day: Avidity Biosciences --- Something's Up???

Author's Note: Every once in a while I see a stock where most analysts predict decreasing Revenue and Earnings but they all seem to recommend it anyway — Here is a good example. Please tell my what...

RNA : 31.80 (+0.25%)
Oracle, Casey's General Stores rise; Vera Bradley, PetMed fall, Wednesday, 6/12/2024

Stocks that traded heavily or had substantial price changes on Wednesday: Oracle, Casey’s General Stores rise; Vera Bradley, PetMed fall

FCX : 40.74 (+0.79%)
RNA : 31.80 (+0.25%)
PETS : 4.09 (+0.25%)
PARAA : 22.69 (-0.24%)
VRA : 2.44 (-3.56%)
CASY : 393.94 (-2.06%)
ORCL : 152.82 (+0.24%)
2 Potentially High-Reward Growth Stocks to Buy Right Now

These two biotechnology stocks could be gearing up for a run.

RNA : 31.80 (+0.25%)
LRMR : 2.54 (-1.17%)
5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 31.06 (+0.49%)
VKTX : 29.16 (-3.03%)
LBPH : 59.98 (+0.03%)
ARQT : 16.78 (+1.08%)
RNA : 31.80 (+0.25%)
Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1

New AOC 1001 data demonstrate improvement in additional functional measures including hand grip, muscle strength and patient reported outcomes, augmenting...

RNA : 31.80 (+0.25%)
Avidity Biosciences to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

RNA : 31.80 (+0.25%)
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

RNA : 31.80 (+0.25%)
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 13, 2023 – USA News Group  –  Sufferers of many different ailments saw reason to grow their hope in 2022 when...

ONCY : 0.6372 (+2.69%)
ONC.TO : 0.92 (+3.37%)
FULC : 3.02 (+1.68%)
RNA : 31.80 (+0.25%)
BCTX : 4.25 (-0.47%)
BCT.TO : 6.08 (-0.98%)
GILD : 105.12 (-2.22%)
Avidity Biosciences Joins with Patient Communities to Raise Awareness During National Muscular Dystrophy Awareness Month as it Advances Three Muscular Dystrophy Clinical Programs

Avidity supports World Duchenne Awareness Day, International Myotonic Dystrophy Awareness Day, FSHD Society Walk & Roll to Cure FSHD and Global Genes Week in...

RNA : 31.80 (+0.25%)
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

RNA : 31.80 (+0.25%)
Avidity Biosciences Receives FDA Orphan Drug Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

RNA : 31.80 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the...

See More

Key Turning Points

3rd Resistance Point 33.84
2nd Resistance Point 32.86
1st Resistance Point 32.29
Last Price 31.80
1st Support Level 30.74
2nd Support Level 29.76
3rd Support Level 29.19

See More

52-Week High 56.00
Fibonacci 61.8% 42.84
Fibonacci 50% 38.78
Fibonacci 38.2% 34.72
Last Price 31.80
52-Week Low 21.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.